Kopp Family Office LLC Grows Holdings in Hawkins, Inc. $HWKN

Kopp Family Office LLC lifted its holdings in Hawkins, Inc. (NASDAQ:HWKNFree Report) by 92.5% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 28,658 shares of the specialty chemicals company’s stock after acquiring an additional 13,767 shares during the quarter. Hawkins accounts for about 2.6% of Kopp Family Office LLC’s holdings, making the stock its 15th biggest holding. Kopp Family Office LLC’s holdings in Hawkins were worth $4,072,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the business. Westwood Holdings Group Inc. lifted its holdings in shares of Hawkins by 31.5% in the 1st quarter. Westwood Holdings Group Inc. now owns 599,015 shares of the specialty chemicals company’s stock worth $63,448,000 after acquiring an additional 143,425 shares during the last quarter. Vaughan Nelson Investment Management L.P. raised its holdings in Hawkins by 37.6% during the 1st quarter. Vaughan Nelson Investment Management L.P. now owns 350,722 shares of the specialty chemicals company’s stock valued at $37,148,000 after buying an additional 95,885 shares during the last quarter. GW&K Investment Management LLC raised its holdings in Hawkins by 3.2% during the 1st quarter. GW&K Investment Management LLC now owns 220,327 shares of the specialty chemicals company’s stock valued at $23,337,000 after buying an additional 6,832 shares during the last quarter. Royce & Associates LP raised its holdings in Hawkins by 8.3% during the 1st quarter. Royce & Associates LP now owns 114,812 shares of the specialty chemicals company’s stock valued at $12,161,000 after buying an additional 8,785 shares during the last quarter. Finally, Raymond James Financial Inc. raised its holdings in Hawkins by 2.8% during the 1st quarter. Raymond James Financial Inc. now owns 109,697 shares of the specialty chemicals company’s stock valued at $11,619,000 after buying an additional 3,010 shares during the last quarter. 69.71% of the stock is currently owned by institutional investors.

Hawkins Price Performance

HWKN opened at $171.37 on Wednesday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.45 and a current ratio of 2.31. The stock has a market capitalization of $3.58 billion, a P/E ratio of 42.21, a P/E/G ratio of 2.44 and a beta of 0.86. The company’s 50-day simple moving average is $169.05 and its two-hundred day simple moving average is $140.58. Hawkins, Inc. has a 52-week low of $98.30 and a 52-week high of $185.50.

Hawkins (NASDAQ:HWKNGet Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The specialty chemicals company reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.07. Hawkins had a net margin of 8.37% and a return on equity of 18.35%. The firm had revenue of $293.27 million for the quarter, compared to analysts’ expectations of $278.76 million. As a group, analysts predict that Hawkins, Inc. will post 4 EPS for the current year.

Hawkins Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were paid a $0.19 dividend. This is a boost from Hawkins’s previous quarterly dividend of $0.18. The ex-dividend date was Friday, August 15th. This represents a $0.76 annualized dividend and a dividend yield of 0.4%. Hawkins’s dividend payout ratio (DPR) is currently 18.72%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. Zacks Research lowered shares of Hawkins from a “strong-buy” rating to a “hold” rating in a report on Monday. BWS Financial upped their price target on shares of Hawkins from $160.00 to $200.00 and gave the company a “buy” rating in a report on Friday, August 1st. Raymond James Financial began coverage on shares of Hawkins in a report on Thursday, July 24th. They issued a “market perform” rating for the company. Finally, Wall Street Zen lowered shares of Hawkins from a “buy” rating to a “hold” rating in a report on Saturday, July 5th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, Hawkins presently has an average rating of “Moderate Buy” and an average price target of $162.50.

Check Out Our Latest Research Report on Hawkins

Hawkins Profile

(Free Report)

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.

Recommended Stories

Want to see what other hedge funds are holding HWKN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hawkins, Inc. (NASDAQ:HWKNFree Report).

Institutional Ownership by Quarter for Hawkins (NASDAQ:HWKN)

Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.